巴黎初创公司 Nabla 近日传来喜讯，其在医疗科技领域的创新产品吸引了大量投资。Nabla 成功完成了 2400 万美元的 B 轮融资，此轮融资由知名投资机构 Cathay Innovation 领衔，ZEBOX Ventures 紧随其后参与投资。这标志着市场对 Nabla 及其人工智能医疗记录助手 Nabla Copilot 的高度认可。
Nabla Copilot，这款于去年三月问世的创新工具，旨在减轻医生的工作负担，提升医疗服务效率。它能够智能转录医生与患者的对话，将口头咨询实时转化为精确的电子病历，从而帮助医生快速、准确地更新临床记录。这一解决方案不仅减少了医生在文书工作上的时间，更让医生能更专注于对患者的直接关怀。
Nabla 的这一轮融资将为公司带来更大的发展动力，有望加速 Nabla Copilot 在全球医疗领域的普及，让更多医疗机构和医生受益于人工智能技术的便利。随着医疗健康数据的日益重要，Nabla 的解决方案有望成为行业标准，引领医疗记录管理的新潮流。
英语如下：
News Title: “AI Medical Assistant Nabla Secures $24 Million in Series B Funding, Aiding Doctors with Intelligent Transcription of Clinical Records”
Keywords: AI in healthcare, Nabla funding, automatic transcription
News Content: Paris-based startup Nabla has recently announced a significant milestone as its innovative medical technology product has piqued investor interest. The company has successfully closed a $24 million Series B funding round, led by prominent investor Cathay Innovation, with ZEBOX Ventures also participating. This development signifies a strong endorsement of Nabla and its AI-driven medical record assistant, Nabla Copilot.
Nabla Copilot, introduced last March, is an innovative tool designed to alleviate doctors’ workload and enhance healthcare efficiency. It intelligently transcribes conversations between doctors and patients, converting oral consultations into precise electronic medical records in real-time, assisting doctors in promptly and accurately updating clinical documentation. This solution not only reduces physicians’ time spent on paperwork but also enables them to focus more on direct patient care.
The latest funding round for Nabla is poised to fuel the company’s growth, potentially accelerating the global adoption of Nabla Copilot in the healthcare sector. As the importance of healthcare data continues to rise, Nabla’s solution is set to become an industry standard, driving a new wave in medical record management.
【来源】https://www.maginative.com/article/nabla-secures-24-million-in-series-b-funding-to-accelerate-healthcare-copilot-rollout/
Views: 13